Equities

Medikit Co Ltd

7749:TYO

Medikit Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,907.00
  • Today's Change-3.00 / -0.10%
  • Shares traded100.00
  • 1 Year change+9.37%
  • Beta0.4206
Data delayed at least 20 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments23,61127,59328,118
Total Receivables, Net5,2855,6915,004
Total Inventory3,8773,2813,627
Prepaid expenses------
Other current assets, total1,7181,6111,793
Total current assets34,49138,17638,541
Property, plant & equipment, net11,47410,43810,835
Goodwill, net2,3381,936--
Intangibles, net1,1381,156127
Long term investments962882928
Note receivable - long term------
Other long term assets123195208
Total assets50,99953,18651,058
LIABILITIES
Accounts payable3,1802,5462,576
Accrued expenses412414397
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total2,1261,7141,442
Total current liabilities5,7194,6744,415
Total long term debt771767747
Total debt771767747
Deferred income tax336331--
Minority interest------
Other liabilities, total45123123
Total liabilities6,8715,8945,286
SHAREHOLDERS EQUITY
Common stock1,2411,2411,241
Additional paid-in capital8,43310,38410,379
Retained earnings (accumulated deficit)39,82638,52037,165
Treasury stock - common(6046)(3244)(3257)
Unrealized gain (loss)200146108
Other equity, total474244136
Total equity44,12947,29245,772
Total liabilities & shareholders' equity50,99953,18651,058
Total common shares outstanding151717
Treasury shares - common primary issue3.082.092.10
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.